What's new in DyslipidemiaLast update of the site: Tuesday August 02, 2022

de Sá João Roberto et al. | Diabetology & Metabolic Syndrome 2022;...
Diabetic kidney disease is the leading cause of entry into renal replacement therapy and is associated...
Belanger, Matthew J.MD et al. | Cardiology in Review 2022; 30(4): 206-13...
Advances in genotyping technologies, bioinformatics tools, and analytical approaches have made it possible...
Kwon Oh Chan et al. | Arthritis Research & Therapy 2022; 24(1):...
Axial spondyloarthritis (axSpA) is a chronic inflammatory arthritis that mainly affects the axial skeleton...
Hiroaki Yagyu et al. | Journal of Diabetes Investigation 2022;...
The International Diabetes Federation reported that there were 424.9 million people with diabetes...
Szili-Torok Tamas et al. | Cardiovascular Diabetology 2022; 21(1):...
Type 2 diabetes is a common disease with worldwide rising incidence and prevalence [1]. Affected patients...
Steenhuis Dennis et al. | Cardiovascular therapeutics 2022 (2022),...
In 2019, approximately two million (12%) Dutch inhabitants were on lipid-lowering therapies, with the...
Young Tamara K. et al. | Journal of diabetes research 2022 (2022),...
Minimal trauma fractures are a global health issue, with an annual toll of 9 million fractures, 740,000...
Brandon K. Bellows PharmD et al. | Journal of the American Heart Association...
Individual clinical and genotype data from the UK Biobank were used to estimate the probability of any...
Lisandro D. Colantonio MD et al. | Journal of the American Heart Association...
Black and White US adults with a history of atherosclerotic cardiovascular disease who had higher lipoprotein(a)...

Bibliographical searchFocus and target to your research of scientific data

Research by journal
824 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Steenhuis Dennis et al. | Cardiovascular therapeutics 2022 (2022),...
In 2019, approximately two million (12%) Dutch inhabitants were on lipid-lowering therapies, with the vast majority on 3-hydroxy-3-methylglutaryl-coe nzyme A (HMG-CoA) reductase inhibitors or statins (97%)...
de Sá João Roberto et al. | Diabetology & Metabolic Syndrome 2022;...
Diabetic kidney disease is the leading cause of entry into renal replacement therapy and is associated with increased morbidity and mortality [1, 2]. In 2007, the Kidney Disease Outcomes Quality Initiative...
Belanger, Matthew J.MD et al. | Cardiology in Review 2022; 30(4): 206-13...
Advances in genotyping technologies, bioinformatics tools, and analytical approaches have made it possible to obtain genetic testing for specific cardiovascular (CV) diseases from a Clinical Laboratory...
Young Tamara K. et al. | Journal of diabetes research 2022 (2022),...
Minimal trauma fractures are a global health issue, with an annual toll of 9 million fractures, 740,000 associated-deaths, and accounting for a loss of 1.75 million disability-adjusted life-years [1]....
Lisandro D. Colantonio MD et al. | Journal of the American Heart Association...
Black and White US adults with a history of atherosclerotic cardiovascular disease who had higher lipoprotein(a) levels had an increased risk for future coronary heart disease events. The association...